✦ LIBER ✦

Golimumab for the Treatment of Rheumatoid Arthritis After the Failure of Previous Disease-Modifying Antirheumatic Drugs: A NICE Single Technology Appraisal

✍ Scribed by Tosh, Jonathan; Archer, Rachel; Davis, Sarah; Stevenson, Matt; Stevens, John W.

Book ID: 120581507
Publisher: Springer International Publishing AG
Year: 2013
Tongue: English
Weight: 235 KB
Volume: 31
Category: Article
ISSN: 1170-7690
DOI: 10.1007/s40273-013-0052-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Golimumab for the treatment of rheumatoi

Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying antirheumatic drugs. Technology appraisal 225. June 2011.

📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 32 KB

Golimumab for the Treatment of Ankylosin

Golimumab for the Treatment of Ankylosing Spondylitis: A NICE Single Technology Appraisal

✍ Armstrong, Nigel; Joore, Manuela; Asselt, Thea; Misso, Kate; Manning, Nathan; To 📂 Article 📅 2013 🏛 Springer International Publishing AG 🌐 English ⚖ 353 KB

Renal toxicity associated with disease-m

Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis

✍ Michael H. Schiff; Andrew Whelton 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Mixed Treatment Comparison of the Treatm

Mixed Treatment Comparison of the Treatment Discontinuations of Biologic Disease-Modifying Antirheumatic Drugs in Adults with Rheumatoid Arthritis

✍ Desai, R. J.; Hansen, R. A.; Rao, J. K.; Wilkins, T. M.; Harden, E. A.; Yuen, A. 📂 Article 📅 2012 🏛 Harvey Whitney Books Company 🌐 English ⚖ 388 KB

German guidelines for the sequential med

German guidelines for the sequential medical treatment of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs

✍ Albrecht, Katinka; Krüger, Klaus; Wollenhaupt, Jürgen; Alten, Rieke; Backhaus, M 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 262 KB

EULAR recommendations for the management

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

✍ Smolen, J. S.; Landewe, R.; Breedveld, F. C.; Dougados, M.; Emery, P.; Gaujoux-V 📂 Article 📅 2010 🏛 BMJ Publishing Group 🌐 English ⚖ 305 KB